Literature DB >> 217561

Discordance of Epstein-Barr Virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titres and lowered in vitro lymphocyte reactivity.

C H Ten Napel, T H The, J Van Egten-Bijker, G C de Gast, M R Halie, M M Langenhuysen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 217561      PMCID: PMC1537550     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  30 in total

1.  Lymphocyte responses to phytohaemagglutinin: age-related effects.

Authors:  L A Fernandez; J M MacSween; G R Langley
Journal:  Immunology       Date:  1976-10       Impact factor: 7.397

2.  Antibody formation in Hodgkin's disease.

Authors:  A C AISENBERG; S LESKOWITZ
Journal:  N Engl J Med       Date:  1963-06-06       Impact factor: 91.245

3.  Epstein-Barr virus (EBV)-associated antibody patterns in relation to the deficiency of cell-mediated immunity in patients with Hodgkin's disease.

Authors:  B Johansson; D Killander; G Holm; H Mellstedt; G Henle; W Henle; G Klein; G Söderberg
Journal:  IARC Sci Publ       Date:  1975

4.  Antibodies against cytomegalovirus-induced early antigens (CMV-EA) in immunosuppressed renal-allograft recipients.

Authors:  T H The; H K Andersen; E S Spencer; G Klein
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

5.  Hodgkin's disease and herpes viruses.

Authors:  M M Langenhuysen; T H The; M R Halie; G C De Gast
Journal:  Neth J Med       Date:  1976       Impact factor: 1.422

6.  A case control study on immunity to two Epstein-Barr virus-associated antigens, and to herpes simplex virus and adenovirus in a population-based group of patients with Hodgkin's disease in Denmark, 1971-73.

Authors:  J Hesse; P H Levine; P Ebbesen; R R Connelly; C H Mordhorst
Journal:  Int J Cancer       Date:  1977-01       Impact factor: 7.396

7.  Relation of cell-mediated immunity to staging, histology and prognosis in untreated patients with Hodgkin's disease.

Authors:  G C De Gast; M R Halie
Journal:  Neth J Med       Date:  1976       Impact factor: 1.422

8.  Antibodies to Epstein-Barr virus, cytomegalovirus, and Australia antigen in Hodgkin's disease.

Authors:  M M Langenhuysen; T Cazemier; B Houwen; T M Brouwers; M R Halie; T H The; H O Nieweg
Journal:  Cancer       Date:  1974-08       Impact factor: 6.860

9.  An immunofluorescence technique with counterstain on fixed cells for the detection of antibodies to human herpesviruses; antibody patterns in patients with Hodgkin's disease and nasopharyngeal carcinoma.

Authors:  F Hilgers; J Hilgers
Journal:  Intervirology       Date:  1976       Impact factor: 1.763

View more
  2 in total

1.  Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A.

Authors:  F Pelloquin; J P Lamelin; G M Lenoir
Journal:  In Vitro Cell Dev Biol       Date:  1986-12

Review 2.  Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin's disease.

Authors:  N Mueller
Journal:  Yale J Biol Med       Date:  1987 Jul-Aug
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.